Minocycline treatment reduces white matter damage after excitotoxic striatal injury

Joanilson S Guimarães1, Marco Aurelio M Freire, Rafael R Lima

  • 1Edmond and Lily Safra International Institute of Neuroscience of Natal, Natal/RN, Brazil.

Brain Research
|March 16, 2010
PubMed

Insights

Minocycline protects white matter damage (WMD) in rat striatum following excitotoxic lesions. This antibiotic preserves oligodendrocytes and reduces myelin impairment, suggesting a role in mitigating neuroinflammation.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • White matter damage (WMD) is a key component of acute striatal injury.
  • Microglial and macrophage activation are implicated in the pathology of WMD.
  • Oligodendrocyte damage and myelin loss are consequences of excitotoxic insults.

Purpose of the Study:

  • To investigate the neuroprotective effects of minocycline in a rat model of striatal excitotoxic injury.
  • To determine if minocycline can mitigate white matter damage and associated cellular pathology.

Main Methods:

  • Induction of excitotoxic lesions in the rat striatum using N-Methyl-d-Aspartate (NMDA) microinjections.
  • Administration of minocycline post-lesion.
  • Assessment of oligodendrocyte integrity (Tau-1 staining) and myelin basic protein (MBP) reactivity.

Main Results:

  • NMDA lesions caused significant striatal damage, oligodendrocyte loss, and reduced MBP reactivity.
  • Minocycline treatment preserved oligodendrocytes (Tau-1 positive cells).
  • Minocycline treatment reduced myelin impairment, as indicated by MBP reactivity.

Conclusions:

  • White matter damage is a significant pathological feature of acute striatal injury.
  • Microglial/macrophage activation contributes to white matter damage in this model.
  • Minocycline exhibits neuroprotective effects by preserving white matter integrity and reducing myelin loss.

Related Concept Videos